Clinical Trials on Mild-to-moderate COVID-19 in New Zealand
Total 683 results
-
Oneness Biotech Co., Ltd.RecruitingMild to Moderate COVID-19Taiwan, United States
-
Ethicon, Inc.RecruitingControlling Mild to Moderate Bleeding During SurgeryUnited States, United Kingdom
-
Syneos HealthUS Specialty Formulations, LLCCompletedSARS-CoV-2 (COVID-19)New Zealand
-
Akesobio Australia Pty LtdCompletedCoronavirus Disease 2019 (COVID-19)New Zealand
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States
-
Croma-Pharma GmbHActive, not recruitingModerate to Severe Midface Volume DeficitUnited States
-
Helius Medical IncNorth Shore University Hospital; Southside Hospital; Transitions of Long IslandUnknown
-
Oryzon Genomics S.A.Alzheimer's Drug Discovery FoundationCompletedMild to Moderate Alzheimer's DiseaseUnited States
-
Universitätsklinikum KölnHannover Medical School; Miltenyi Biomedicine GmbH; ZKS KölnTerminatedModerate COVID-19-infectionGermany
-
Helius Medical IncKessler Institute for RehabilitationUnknown
-
PfizerCompleted
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
Jiangsu Rec-Biotechnology Co., Ltd.Iqvia Pty LtdCompleted
-
Alkahest, Inc.CompletedAlzheimer Disease | Mild to Moderate Alzheimer DiseaseUnited States
-
Helius Medical IncRecruitingGait Impairment Due to Mild/Moderate Multiple Sclerosis (MS)United States
-
Actavis Inc.Watson Laboratories, Inc.CompletedBACTERIAL VAGINOSIS | Signs and Symptoms to be Evaluated and Recorded Include | Vaginal Discharge Color, Odor, and Consistency | Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe | Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or SevereUnited States, Dominican Republic, Puerto Rico
-
Egalet LtdCompletedModerate-to-severe Chronic Noncancer PainUnited States
-
Atlantic Health SystemCompletedNurse | in Northern New Jersey | Providing Care to Adults With Covid-19United States
-
Mesoblast International SàrlNo longer availableModerate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19United States
-
AbbottCompletedModerate to Severe Chronic, Non-malignant PainUnited States
-
Bristol-Myers SquibbTerminatedPsoriasis, Moderate to SevereUnited States
-
HanAll BioPharma Co., Ltd.CompletedMild to Moderate Atopic DermatitisUnited States
-
AbbVieCompleted
-
MallinckrodtCompletedMild or Moderate Surgical BleedingUnited States, Netherlands, United Kingdom, Belgium
-
Valneva Austria GmbHCompletedSARS-CoV-2 InfectionNew Zealand, Netherlands
-
Jonathann Kuo, MDActive, not recruitingSARS-CoV2 Infection | Post-COVID-19 Syndrome | Dysautonomia | Post Acute COVID-19 Syndrome | Long COVID | Long Covid19 | COVID-19 Recurrent | Post-Acute COVID-19 | Post-Acute COVID-19 Infection | Post Acute Sequelae of COVID-19 | Dysautonomia Like Disorder | Dysautonomia Orthostatic Hypotension Syndrome | Post... and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque PsoriasisUnited States
-
Edwards LifesciencesTerminatedModerate to High-risk Noncardiac SurgeryUnited States
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Sun Pharmaceutical Industries LimitedRecruitingModerate to Severe Plaque PsoriasisUnited States, El Salvador
-
Janssen Biotech, Inc.CompletedModerate to Severe Plaque PsoriasisUnited States
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19United States, United Kingdom, Belgium, Spain, France, Germany, Philippines, Brazil, Colombia, South Africa
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Oregon Research InstituteCompletedCannabis Use Disorder, Mild | Cannabis Use Disorder, ModerateUnited States
-
AbbVie (prior sponsor, Abbott)Paragon BiomedicalCompletedModerate to Severe Plaque PsoriasisUnited States
-
Genzyme, a Sanofi CompanyCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
Regeneron PharmaceuticalsSanofiCompletedModerate to Severe Atopic Hand and Foot DermatitisUnited States, Germany, Japan, Poland
-
TakedaNimbus Lakshmi, Inc.; Innovaderm Research Inc.CompletedModerate to Severe Plaque PsoriasisUnited States, Canada
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
-
Icahn School of Medicine at Mount SinaiNational Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health... and other collaboratorsActive, not recruitingTricuspid Regurgitation | Mild Tricuspid Regurgitation | Moderate Tricuspid RegurgitationUnited States, Canada, Germany
-
University of Witten/HerdeckeInstitut für Rehabilitationsforschung NorderneyCompletedPost-COVID-19 Syndrome | Long-COVID-19 SyndromeGermany
-
Astellas Pharma IncBiogenCompleted
-
Sun Pharmaceutical Industries LimitedActive, not recruitingChronic Plaque Psoriasis | Moderate to Severe Nail PsoriasisUnited States, Australia
-
Vivek ReddyCompletedCOVID 19 Cardiac | COVID 16 Arrhythmia | COVID 19 DeathUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
Bausch Health Americas, Inc.TerminatedModerate to Severe Plaque PsoriasisUnited States, Austria, France, Poland, Australia, Czechia, Canada, Hungary, Portugal, Spain, Netherlands
-
Novartis PharmaceuticalsCompletedModerate to Severe Nail PsoriasisGermany, Belgium, Spain, United States, Australia, United Kingdom, Denmark, Czechia, Greece
-
Egalet LtdCompletedModerate-to-severe Chronic Low Back PainUnited States
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Canada
-
APRINOIA Therapeutics, LLCActive, not recruitingHealthy Volunteers | Alzheimer's Disease | Mild Cognitive Impairment Due to Alzheimer's DiseaseUnited States